US approves breakthrough HIV jab – but aid cuts mean it may not get to millions in need - FDA approval paves the way for the jab to roll out across the world. But with funding being slashed, will it get to the people who need it?

Learn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.

A twice-yearly injectable drug for the prevention of HIV infection has been approved by the United States’ Food and Drug Administration. With better compliance expected — instead of daily pills on a shot every two months that people have to take at the moment — it is one of the most anticipated developments in the field of HIV prevention.